alphaveGKB₹65.00

GKB Ophthalmics Limited

Annual Quarterly₹ CrorePeersFABTECH LAXMIDENTL TARSONS FISCHER

View

	In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023
	Revenue from Operations	27.7
	Other Income	2.1
	Total Income	29.8
	Expenses
	+ Cost of Materials Consumed	13.6
	+ Changes in Inventories	0.1
	+ Employee Benefit Expense	7.5
	+ Finance Costs	1.5
	+ Depreciation & Amortisation	2.5
	+ Other Expenses	7.7
	Total Expenses	32.9
	EBITDA	-1.1
	EBIT	-3.6
	Profit
	Pretax Income	-3.0
	+ Deferred Tax	-0.2
	Tax Expense	-0.2
	Net Income	-2.9
	+ Other Comprehensive Income	-0.0
	Total Comprehensive Income	-2.9
	Per Share
	Basic EPS	-5.72
	Diluted EPS	-5.72
	Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
	Gross Profit	14.1
	Gross Margin %	50.69

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY23 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.